Alnylam Pharmaceuticals, Inc. (ALNY) stock has gained 35.91% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ALNY stock a score of 66 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 89. ALNY's rank also includes a long-term technical score of 86. The fundamental score for ALNY is 22. In addition to the average rating from Wall Street analysts, ALNY stock has a mean target price of 167.6. This means analysts expect the stock to climb 7.49% over the next 12 months.
What's Happening with ALNY Stock Today
Alnylam Pharmaceuticals, Inc. (ALNY) stock is lower by -8.29% while the S&P 500 is lower by -1.41% as of 1:01 PM on Wednesday, Jan 27. ALNY is lower by -$14.10 from the previous closing price of $170.02 on volume of 559,685 shares. Over the past year the S&P 500 has gained 15.84% while ALNY has gained 35.91%. ALNY lost -$7.83 per share in the over the last 12 months.